← All companies

KIDS

OrthoPediatrics Corp.

KIDS Nasdaq Surgical & Medical Instruments & Apparatus EDGAR ↗

$20.87

+0.76 +3.78%

Key statistics

from XBRL data in SEC filings

Market cap

$536M

Revenue (TTM)

$243M

Net income (TTM)

-$39.7M

EPS (TTM)

$-1.68

P/E ratio

—

Dividend yield

—

Free cash flow

-$16.0M

Cash

$12.2M

Total assets

$502M

Gross margin

73.1%

52-week range

$14.42 – $22.80

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 4, 2026 10-Q Quarter ended 2026-03-31 May 1, 2026 8-K Regulation FD disclosure Apr 30, 2026 8-K Results of operations (earnings release) Apr 30, 2026 8-K Entered a material agreement; Took on a direct financial obligation Apr 1, 2026 10-K Fiscal year ended 2025-12-31 Mar 4, 2026 8-K Regulation FD disclosure Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Regulation FD disclosure Jan 12, 2026 8-K Results of operations (earnings release) Jan 12, 2026 10-Q Quarter ended 2025-09-30 Oct 29, 2025 8-K Regulation FD disclosure Oct 28, 2025 8-K Results of operations (earnings release) Oct 28, 2025 8-K Results of operations (earnings release) Oct 9, 2025 8-K Director or officer change Aug 11, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Regulation FD disclosure Aug 5, 2025 8-K Results of operations (earnings release) Aug 5, 2025 8-K Regulation FD disclosure Aug 5, 2025 8-K Shareholder vote results May 27, 2025 8-K Entered a material agreement; Unregistered sale of equity May 14, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Regulation FD disclosure May 7, 2025 8-K Results of operations (earnings release) May 7, 2025 8-K Regulation FD disclosure Mar 6, 2025 10-K Fiscal year ended 2024-12-31 Mar 5, 2025 8-K Results of operations (earnings release) Mar 4, 2025 8-K Regulation FD disclosure Jan 14, 2025 8-K Results of operations (earnings release) Jan 13, 2025 8-K Regulation FD disclosure Nov 12, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 6, 2024 8-K Director or officer change Oct 18, 2024 8-K Regulation FD disclosure Sep 12, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Aug 12, 2024 8-K Regulation FD disclosure Aug 9, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release) Aug 5, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure; Other events Aug 5, 2024 8-K Shareholder vote results May 28, 2024